Friday, 31 March 2017

U.S. judge invalidates Acorda multiple sclerosis drug patents

(Reuters) - A federal judge in Delaware on Friday struck down key patents held by Acorda Therapeutics related to its multiple sclerosis drug Ampyra.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)